Hyliion is trading 5.17% up at $4.07 after investors positioned ahead of its August 11, 2026 Q2 earnings release.

  • Analysts expect a $0.09-per-share loss and $2.40 million in revenue, with attention on KARNO commercialization.
  • Recent developments include a $41.7 million U.S. Navy contract and successful multi-module testing; no source explicitly confirms either caused the August 10 gain.